Phenylpiracetam

Nootropic / Ergogenic

Focus, stamina and cold-tolerance positioning

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: Racetam
Primary mechanism: Racetam + stimulant-like mechanisms
Primary market use: Cognition/performance

Pharmacology

Molecular weight (Da): 218.3
Oral bioavailability: High
Half-life: ~3-5 h
Route tags: Oral
Evidence level: Human/research
Clinical status: Research/prohibited in sport
Value-for-money score: 5 / 10

Reported protocol signal

No popular protocol verified yet; keep as reference compound until protocol signal is added.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Transient; WADA prohibited

Sources

https://www.wada-ama.org/en/prohibited-list